Form 4: Artivion SVP, Clinical & MD Affairs, Marshall S. Stanton, Reports Stock Sales to Cover Tax Obligations

Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc., reports selling shares of common stock to cover tax withholding obligations upon the vesting of restricted stock units.

Summary

• On February 24, 2025, Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc., sold a total of 4,687 shares of common stock.
• The sales were executed at a price of $27.306 per share.
• These transactions were conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following these transactions, Stanton directly owns 79,845 shares of Artivion, Inc. common stock.

Sentiment

Score: 5

Explanation: This is a neutral event. The stock sales are related to tax obligations and do not necessarily reflect a change in the executive's confidence in the company.

Future Outlook

There is no future outlook provided in this document.

Management Comments

• The sale was to satisfy tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary transaction.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who sell shares of their company's stock. It is typical for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates